Last updated on July 2020

Lynparza Breast Cancer Clinical Experience Investigation


Brief description of study

To characterise the development of ADRs of bone marrow depression in patients under actual post-marketing use

Detailed Study Description

To characterise the development of adverse drug reactions (ADRs) of bone marrow depression in patients with unresectable or recurrent BRCA mutated HER2 negative breast cancer who have previously received anticancer chemotherapy under actual post-marketing use.

Clinical Study Identifier: NCT03590938

Find a site near you

Start Over

Research Site

Osaka, Japan
6.1miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.